non glp 1 oral medications New GLP-1 Guidelines for Type 2 Diabetes in 2025 Oral GLP-1 Orforglipron Is Approved

A randomized, double-blind, placebo-controlled study conducted has evaluated the effects of taking Spirulina supplements on immune response in healthy adult in Korea (Park et al

In certain contexts, this interaction appears to suppress the apoptotic removal of senescent cells

Our studies reveal that l-carnitineTMA is a multistep biochemical transformation mediated by multiple members of the gut microbial community via formation of an intermediate, BB, previously shown to be proatherogenic in animal models

Semaglutide remains the most prescribed ADM medication, and tirzepatide continues to be the second-most prescribed medication (it surpassed dulaglutide in late 2023)